COVID-19 Vaccine Participant Develops Neurological Symptoms, AstraZeneca Pauses Trial

On Tuesday, AstraZeneca announced a pause on its experimental COVID-19 vaccine trial after a woman in the UK developed a “suspected serious reaction.” The company is also conducting trials in the U.S., South Africa and Brazil, with enrollment

The post COVID-19 Vaccine Participant Develops Neurological Symptoms, AstraZeneca Pauses Trial appeared first on Global Research.

On Tuesday, AstraZeneca announced a pause on its experimental COVID-19 vaccine trial after a woman in the UK developed a “suspected serious reaction.” The company is also conducting trials in the U.S., South Africa and Brazil, with enrollment

The post COVID-19 Vaccine Participant Develops Neurological Symptoms, AstraZeneca Pauses Trial appeared first on Global Research.


Go to Source
Author: Jeremy Loffredo

Comments